DrugPatentWatch Database Preview
INTRON A Drug Profile
» See Plans and Pricing
Summary for Tradename: INTRON A
Patents: | 1265 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Recent Clinical Trials: | See clinical trials for INTRON A |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for INTRON A |
Recent Clinical Trials for INTRON A
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Roswell Park Cancer Institute | Phase 1/Phase 2 |
Editas Medicine, Inc. | Phase 1/Phase 2 |
Allergan | Phase 1/Phase 2 |
Recent Litigation for INTRON A
Identify key patents and potential future biosimilar entrants
District Court Litigation
Case Name | Date |
---|---|
Bay State Milling Company v. Arcadia Biosciences, Inc. | 2019-04-01 |
Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC | 2018-12-19 |
Boston Heart Diagnostics Corporation v. MD Labs, Inc. | 2018-01-04 |
PTAB Litigation
Petitioner | Date |
---|---|
Regeneron Pharmaceuticals, Inc. | 2019-09-20 |
Regeneron Pharmaceuticals, Inc. | 2019-05-14 |
Baylor College of Medicine | 2018-04-18 |
Pharmacology for INTRON A
Ingredient-type | Interferon Alfa-2b Interferon-alpha |
Company Disclosures: US Patents for INTRON A
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Schering Corporation (Madison, NJ) | 2002-11-19 | RX | company | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Biogen N.V. (Curacao, AN) | 2002-07-23 | RX | company | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Schering Corporation (Kenilworth, NJ) | 2039-03-29 | RX | company | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Schering Corporation (Kenilworth, NJ) | 2014-10-11 | RX | company | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) | 2020-08-26 | RX | company | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | Schering Corporation (Madison, NJ) | 2002-11-19 | RX | company | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for INTRON A
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | IDENIX PHARMACEUTICALS LLC (Cambridge, MA) | 2039-02-26 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Cipla Limited (Mumbia, IN) | 2035-12-09 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | YALE UNIVERSITY (New Haven, CT) | 2021-05-01 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA) | 2033-03-14 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | 2036-04-01 | RX | search | ||
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for INTRON A
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 91342 | Start Trial |
European Patent Office | 1044987 | Start Trial |
European Patent Office | 0461225 | Start Trial |
Canada | 2321269 | Start Trial |
Canada | 1339684 | Start Trial |
Eurasian Patent Organization | 200800083 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for INTRON A
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
91648 | Luxembourg | Start Trial | 91648, EXPIRES: 20150220 |
91013 | Luxembourg | Start Trial | |
132010901806069 | Italy | Start Trial | AUTHORISATION NUMBER(S) AND DATE(S): EU/1/09/609/001-002, 20100125 |
PA2017037 | Lithuania | Start Trial | PRODUCT NAME: NUSINERSENAS ARBA JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1188/001 20170530 |
2003C/006 | Belgium | Start Trial | PRODUCT NAME: MOROCTOCOG ALFA; REGISTRATION NO/DATE: EU/1/99/103/001 19990413 |
132017000128699 | Italy | Start Trial | PRODUCT NAME: NUSINERSEN O SUOI SALI(SPINRAZA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1188, 20170601 |
>Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |